The Nurse View: Best Practices in Multiple Myeloma

Slides:



Advertisements
Similar presentations
Multiple Myeloma: Is it now a curable disease?
Advertisements

Pharmacoepidemiology Of Multiple Myeloma Treatment Patterns, Safety And Effectiveness In Real Life Conditions Aurore Palmaro Thesis directors: Dr Maryse.
Future Strategies for Myeloma
Overall Goal. Clinical Conversations: Nursing Care for Patients With Multiple Myeloma.
Myeloma hope new treatment in the horizon
Perspectives on Managing Polycythemia Vera for the Nurse Practitioner and Physician Assistant.
How have evolutions in strategies for the treatment of relapsed/refractory multiple myeloma translated into improved outcomes for patients?  Pieter Sonneveld,
Nurses' Toolbox: How to Improve Patient Outcomes in Multiple Myeloma
Please note this program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.
Pharmacy Perspectives in Multiple Myeloma: Relapsed and/or Refractory Disease.
Clinical Considerations in the Management of EGFR-Mutated Advanced NSCLC.
Hot Off the Press: Changes in the Landscape of Multiple Myeloma
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Improving the Diagnosis and Treatment of Seizures in Long-term Care
Risk Stratification in PAH: What Do the Latest Data Suggest?
Challenges in the Diagnosis of MS: Physician and Nurse Perspectives
A Comparison of the Efficacy of Immunomodulatory-containing Regimens in Relapsed/Refractory Multiple Myeloma: A Network Meta-analysis  Meletios Athanasios.
Does One Size Fit All in Obesity Management?
Beyond Supportive Care for Lower-Risk Myelodysplastic Syndrome
Charting Progress in MS Diagnosis and Treatment for Today and Tomorrow
The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer
Hot Topics in Hemophilia Nursing
Advances in Dry Eye.
Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry ( )  Sundar Jagannath, Rafat Abonour, Brian.
Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.
Multiple Myeloma: Diagnosis and Treatment
Treating Transplant-Ineligible Patients With Multiple Myeloma
Assessing Newer Treatment Approaches for Multiply Relapsed Multiple Myeloma.
Goals of Therapy in Relapsed CLL
Therapy for Relapsed Multiple Myeloma
A Comprehensive Strategy Toward the Patient With Rhinorrhea
Managing IBD in Children
Aligning Patients and Clinicians: Optimizing Outcomes in Metastatic NSCLC.
Tailoring Hemophilia Prophylaxis Therapy
A Focus on Polycythemia Vera for Nurse Practitioners and Physician Assistants.
Pharmacist Perspectives on Novel Agents in Multiple Myeloma
Seizures in the Elderly: Treatment and Special Considerations
Managing Depression is a Team Effort:
Optimizing Frontline Care for Older Patients With Multiple Myeloma
Translating the Latest and Greatest Advances in PAH Into Clinical Practice.
Advances in Multiple Myeloma: Data Highlights and Analysis from the 2015 Hematology/Oncology Conferences.
Approaches in Newly Diagnosed Multiple Myeloma: When and What
Staying Abreast of Best Practices Across the Clinical Continuum
Managing Multiple Myeloma in the Elderly
Program Goals Overview Is NEDA a Reasonable Target?
Talking With Your Patients About Excessive Sweating
Case 1 Presentation Case 1 (cont) Assessment and Recommendations.
Relapsed/Refractory Myeloma: Foundational Knowledge Essential to Improve Patient Outcomes.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Managing Your Patient’s Maintenance Therapy for Multiple Myeloma
Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice.
New ELN Recommendations
The Role of Maintenance Therapy in Multiple Myeloma
The Changing Field of Melanoma: Ipilimumab.
A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.
Therapy for Relapsed Multiple Myeloma
Proteasome Inhibitors and Patients
On the Cusp: New Approaches for Multiple Myeloma
Program Goals Background: Anticoagulation in Patients With VTE.
Improving Adherence to Antiplatelet Therapy After an ACS Event
Perspective on the Multidisciplinary Management of PAH
Pomalidomide plus Low-Dose Dexamethasone in Myeloma Refractory to Both Bortezomib and Lenalidomide: Comparison of Two Dosing Strategies in Dual-Refractory.
Renal Function and Myeloma Therapeutics
Program Goals Overview Is NEDA a Reasonable Target?
Clinical Challenges in the Patient With Relapsed Multiple Myeloma
The Changing Goals of CML Therapy
Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM by Sundar Jagannath, Rafat Abonour,
Risk Stratification in MDS
Utilizing MRD Assessment in Community Practice
Maintenance therapies in Multiple Myeloma
Presentation transcript:

The Nurse View: Best Practices in Multiple Myeloma

MM Overview

Newly Diagnosed MM Case Study

MM Diagnosis CRAB Criteria

Redefining MM IMWG Updated Diagnostic Criteria

Case Study Treatment Considerations

Newly Diagnosed MM Risk Stratification

Newly Diagnosed MM Nurse-Patient Communication

Newly Diagnosed MM Assessing Fitness and Comorbidities

Lenalidomide Supportive Care Strategies

Bortezomib Supportive Care Strategies

Dexamethasone Supportive Care Strategies

MM Supportive Care and Survivorship Issues

MM Use of Supplements

Pomalidomide Third-Generation IMiD

Carfilzomib Second-Generation PI

Panobinostat HDAC Inhibitor

Monoclonal Antibodies Nursing Considerations

Nurse Best Practices in MM Take-Home Points

Abbreviations

Abbreviations (cont)

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)